1-11 of 11
directly observed therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Idelalisib Treatment Interruption with or without Dose Reduction on Outcomes in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Shuo Ma, MD PhD, Rebecca J Chan, MD PhD, Lin Gu, MS, Guan Xing, PhD, Nishan Rajakumaraswamy, MD, Bianca Ruzicka, PhD, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5468.
https://doi.org/10.1182/blood-2019-124541
Published: 2019
Journal Articles

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting

David Andorsky, MD, Rebecca J Chan, MD PhD, Jamyia Clark, MPH, Bianca Ruzicka, PhD, Nicholas James Robert, MD, Farrukh T. Awan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2810.
https://doi.org/10.1182/blood-2019-124013
Published: 2019
Journal Articles

Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study

Vania T.M. Hungria, MD PhD, Hans C. Lee, MD, Rafat Abonour, MD, Robert M. Rifkin, MD, Evangelos Terpos, MD PhD, Xavier Leleu, MD PhD, Caitlin L. Costello, MD, Frits van Rhee, MD PhD, Katja C. Weisel, MD, Noemi Puig, MD PhD, Jesus G. Berdeja, MD, Gordon Cook, MB ChB, PhD FRCP(Glas), FRCPath, Saad Z. Usmani, MD FACP, Michael A. Thompson, MD PhD FASCO, Mario Boccadoro, Jeffrey A. Zonder, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Roman Hajek, Prof, MD PhD, Suzanne R. Fanning, DO, Kevin Boyd, MB BS, BSc, MRCP, FRCPath, PhD, Jim Omel, MD, Mira Armour, BSc, Kathryn E. Morgan, Ronak S. Patel, Gary L. Carlson, Renda H. Ferrari, PhD, Dawn Marie Stull, Pharm.D., BCOP, Kaili Ren, PhD, Dasha Cherepanov, PhD, James V. Pottala, PhD, Ajai Chari, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1887.
https://doi.org/10.1182/blood-2019-125749
Published: 2019
Journal Articles

Treatment Sequencing in Patients with Relapsed/Refractory Multiple Myeloma after Daratumumab Treatment: Real-World Findings from a Pooled Data Analysis of Preamble and the Mckesson Electronic Medical Record Database

Ravi Vij, MBBS, Clara Chen, PhD BS, MS, Christopher A. Yasenchak, MD, Catherine Davis, PharmD, David J. Kuter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3284.
https://doi.org/10.1182/blood-2018-99-112074
Published: 2018
Journal Articles

Survival Outcomes Following Idelalisib Interruption in the Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Shuo Ma, MD PhD, Rebecca J Chan, MD PhD, Wei Ye, PhD, Guan Xing, PhD, Carrie Ellen Brubaker, PhD, Caroline Roudet, PharmD, MBA, Bianca Ruzicka, PhD, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3149.
https://doi.org/10.1182/blood-2018-99-110655
Published: 2018
Journal Articles

Exploring the Tumor Clonal Dynamics between Diffuse Large B-Cell Lymphomas and Bone Marrow Involvement By Deep Immunoglobulin Heavy Chain VDJ Sequencing

Anna S Nam, MD, Jiao Ma, PhD, Ayako Miyaguchi, PhD, David Redmond, Kui Nie, PhD, Olivier Elemento, PhD, Wayne Tam, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2737.
https://doi.org/10.1182/blood.V130.Suppl_1.2737.2737
Published: 2017
Journal Articles

Treatment Sequencing Patterns Observed in Patients Treated Initially with Lenalidomide/Dexamethasone Combination As Frontline Multiple Myeloma Therapy

Clara Chen, PhD BS, MS, Ravi Potluri, Hemanth Kanakamedala, Eros Papademetriou, Christopher A. Yasenchak, MD, Sandip Ranjan, Hitesh Bhandari, Jasdeep Mann, Catherine Davis
Journal: Blood
Blood (2017) 130 (Supplement 1): 3127.
https://doi.org/10.1182/blood.V130.Suppl_1.3127.3127
Published: 2017
Journal Articles

Duration of Treatment of Multiple Myeloma Regimens in Patients with Relapsed or Refractory Multiple Myeloma: Findings in US Clinical Practice Settings

Ravi Potluri, Hemanth Kanakamedala, Clara Chen, PhD BS, MS, Christopher A. Yasenchak, MD, Sandip Ranjan, Eros Papademetriou, Hitesh Bhandari, Jasdeep Mann, Catherine Davis
Journal: Blood
Blood (2017) 130 (Supplement 1): 1844.
https://doi.org/10.1182/blood.V130.Suppl_1.1844.1844
Published: 2017
Journal Articles

Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, MD, Katja Weisel, MD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Andrew Spencer, MD, Stefan Knop, MD, Nizar J. Bahlis, MD, Christoph Renner, MD, Xin Yu, PhD, Kevin Hong, MS, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Jesús F. San Miguel, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 408.
https://doi.org/10.1182/blood.V122.21.408.408
Published: 2013
Journal Articles

Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients

Adam Cohen, Lakshmanan Krishnamurti, MD, Susan E. Creary, MD
Journal: Blood
Blood (2012) 120 (21): 3538.
https://doi.org/10.1182/blood.V120.21.3538.3538
Published: 2012
Journal Articles

Mobile Directly Observed Therapy: Monitoring and Improving Hydroxyurea Adherence in Pediatric Sickle Cell Patients

Susan E. Creary, MD, Mark T Gladwin, MD, Lakshmanan Krishnamurti, MD
Journal: Blood
Blood (2012) 120 (21): 2060.
https://doi.org/10.1182/blood.V120.21.2060.2060
Published: 2012